Horse Tea (06980): Hong Kong public offering was oversubscribed by 2680.04 times, with an offer price of HK$50 per share.
Ba Ma Tea Company (06980) announced the distribution results, with the company issuing 9 million H shares globally, with the Hong Kong public offering accounting for 10...
Bama Tea Company (06980) announced the results of its distribution, with a global sale of 9 million H shares, of which 10% were sold publicly in Hong Kong and 90% were sold internationally. The sale price per share was HK$50, with a net raise of approximately HK$390 million from the global sale. Each lot of H shares consists of 100 shares, and it is expected that H shares will begin trading on the Stock Exchange on October 28, 2025, at 9:00 am Hong Kong time.
The public sale in Hong Kong was oversubscribed 2680.04 times, while the international sale was oversubscribed 13.58 times.
Related Articles

US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.
US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


